WordNet

inflammation of the urinary bladder and ureters
a response of body tissues to injury or irritation; characterized by pain and swelling and redness and heat (同)redness, rubor
arousal to violent emotion (同)inflaming
a bag that fills with air
a distensible membranous sac (usually containing liquid or gas) (同)vesica

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 間質性膀胱炎／膀胱痛症候群の病因、臨床的特徴、診断 pathogenesis clinical features and diagnosis of interstitial cystitis bladder pain syndrome
2. 尿路上皮（移行上皮）膀胱癌の疫学および病因 epidemiology and etiology of urothelial transitional cell carcinoma of the bladder
3. 膀胱腫瘍の病理 pathology of bladder neoplasms
4. 膀胱カテーテルの合併症および予防戦略 complications of urinary bladder catheters and preventive strategies
5. 膀胱癌の臨床症状、診断、および病期分類 clinical presentation diagnosis and staging of bladder cancer

Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation.

Merriam FV, Wang ZY, Hillard CJ, Stuhr KL, Bjorling DE.SourceDepartment of Surgical Sciences, School of Veterinary Medicine, Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Department of Urology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
BJU international.BJU Int.2011 Oct;108(7):1145-9. doi: 10.1111/j.1464-410X.2010.09583.x. Epub 2010 Aug 26.
Study Type - Aetiology (case series) Level of Evidence?4OBJECTIVE: ??To determine (i) the presence of fatty acid amide hydrolase (FAAH) in the urinary bladder; (ii) whether or not endogenous fatty acid ethanolamides are synthesized by the bladder; (iii) the effects of FAAH inhibition on referr
PMID 20804480

Contemporary Management of Lower Urinary Tract Disease With Botulinum Toxin A: A Systematic Review of Botox (OnabotulinumtoxinA) and Dysport (AbobotulinumtoxinA).

Mangera A, Andersson KE, Apostolidis A, Chapple C, Dasgupta P, Giannantoni A, Gravas S, Madersbacher S.SourceSheffield Teaching Hospitals NHS Trust, Sheffield, UK.
European urology.Eur Urol.2011 Oct;60(4):784-95. Epub 2011 Jul 13.
CONTEXT: The use of botulinum toxin A (BoNTA) in the treatment of lower urinary tract dysfunction has expanded in recent years and the off-licence usage list includes neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity (IDO), painful bladder syndrome (PBS), and lower urinary tra
PMID 21782318

山本致之,西村健作,上田倫央,川村憲彦,氏家剛,任幹夫,三好進
泌尿器科紀要 56(9), 517-520, 2010-09
… Considering possible infection and inflammation remaining, we decided to perform abdominal repair of the vesicovaginal fistula about three months after the operation. … During the operation, a fistula 3 mm in diameter was confirmed just adjacent to the distal edge of the polypropylene mesh which had been fixed between the bladder and the anterior wall of vagina. …
NAID 120002484974